Literature DB >> 11748047

Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy.

James R Klinger1, Rod R Warburton, Linda Pietras, Paula Oliver, Jennifer Fox, Oliver Smithies, Nicholas S Hill.   

Abstract

Targeted disruption of the gene for natriuretic peptide receptor-A (NPR-A) worsens pulmonary hypertension and right ventricular hypertrophy during hypoxia, but its effect on left ventricular mass and systemic pressures is not known. We examined the effect of 3 wk of hypobaric hypoxia (0.5 atm) on right and left ventricular pressure and mass in mice with 2 (wild type), 1, or 0 copies of Npr1, the gene that encodes for NPR-A in mice. Under normoxic conditions, right ventricular peak pressure (RVPP) was greater in 0 than in 2 copy mice, but there were no genotype-related differences in carotid artery PP (CAPP). The left ventricular free wall weight-to-body weight (LV/body wt) ratio was greater in 0 than in 2 copy mice and there was a trend toward a greater right ventricular weight-to-body weight (RV/body wt) ratio. Three weeks of hypoxia increased RVPP and RV/body wt in all genotypes. The increase in RVPP was similar in all genotypes (11-14 mmHg), but the hypoxia-induced increase in RV/body wt was more than twice as great in 0 copy mice than in 2 copy mice (1.11 +/- 0.06 to 2.65 +/- 0.46 vs. 0.96 +/- 0.04 to 1.4 +/- 0.09, P < 0.05). Chronic hypoxia had no effect on CAPP in any genotype and did not effect LV/body wt in 1 or 2 copy mice, but increased LV/body wt 41% in 0 copy mice. We conclude that absent expression of NPR-A worsens right ventricular hypertrophy and causes left ventricular hypertrophy during exposure to chronic hypoxia without increasing pulmonary or systemic arterial pressure responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748047     DOI: 10.1152/ajpheart.2002.282.1.H58

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  14 in total

Review 1.  The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Authors:  Kailash N Pandey
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

2.  Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/- mice.

Authors:  Matthew R Alexander; Joshua W Knowles; Toshio Nishikimi; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-04-17       Impact factor: 8.311

3.  Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin.

Authors:  Amy J Malhowski; Haider Hira; Sarah Bashiruddin; Rod Warburton; June Goto; Blanton Robert; David J Kwiatkowski; Geraldine A Finlay
Journal:  Hum Mol Genet       Date:  2011-01-06       Impact factor: 6.150

4.  Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1.

Authors:  Ali Pedram; Mahnaz Razandi; Mark Aitkenhead; Ellis R Levin
Journal:  J Biol Chem       Date:  2005-05-16       Impact factor: 5.157

5.  Cardiac atria are the primary source of ANP release in hypoxia-adapted rats.

Authors:  Brian Casserly; Linda Pietras; Joy Schuyler; Richard Wang; Nicholas S Hill; James R Klinger
Journal:  Life Sci       Date:  2010-08-05       Impact factor: 5.037

Review 6.  B-type natriuretic Peptide and the right heart.

Authors:  Lok Bin Yap
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

7.  Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.

Authors:  Ali Pedram; Mahnaz Razandi; Dennis Lubahn; Jinghua Liu; Mani Vannan; Ellis R Levin
Journal:  Endocrinology       Date:  2008-03-27       Impact factor: 4.736

8.  Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation.

Authors:  Kailash N Pandey
Journal:  J Am Soc Hypertens       Date:  2008 Jul-Aug

9.  Troponin T and pro-B-type natriuretic Peptide in fetuses of type 1 diabetic mothers.

Authors:  Noirin E Russell; Mary F Higgins; Michael Amaruso; Michael Foley; F M McAuliffe
Journal:  Diabetes Care       Date:  2009-08-18       Impact factor: 17.152

10.  Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.